BSEM Share Price Performance
US$4.31
-7.69 (-64.11%)
87.9% undervalued intrinsic discount
US$35.50
Fair Value
Price US$4.31
AnalystConsensusTarget US$35.50
Fair ValueUS$49.56
Share PriceUS$4.31
91.3% undervalued intrinsic discount
BioStem Technologies, Inc. Stock Price
- 1 Narratives written by author
- 1 Comments on narratives written by author
- 41 Fair Values set on narratives written by author
BSEM Community Narratives
AN
Fair Value US$49.56 90.3% undervalued intrinsic discount
VENDAJE AC National Launch And BioRetain Data To Drive Future Market Expansion
0users have liked this narrative
1users have commented on this narrative
17users have followed this narrative
BioStem Technologies, Inc. Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- 1.57
- Gross Margin
- 96.97%
- Net Profit Margin
- 8.55%
- Debt/Equity Ratio
- 6.6%
BioStem Technologies, Inc. Competitors
Snowflake Analysis
About BSEM
- Founded
- 2006
- Employees
- n/a
- CEO
- WebsiteView website
BioStem Technologies, Inc., a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases. The company is also engages in the repackaging and distribution of active pharmaceutical ingredients and other pharmaceutical compounding supplies; and develops and markets nutraceutical products under the Dr. Dave’s Best and Nesvik Organics brands, as well as other non-proprietary products in the United States and internationally. The company sells products through e-commerce platforms. BioStem Technologies, Inc. was incorporated in 2006 and is based in Pompano Beach, Florida.
Market Insight
Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading
U.S. Market Performance
- 7 Days: -2.7%
- 3 Months: 5.1%
- 1 Year: 13.4%
- Year to Date: 11.7%
Over the last 7 days, the market has dropped 2.7%, driven by a loss of 2.5% in the Information Technology sector. As for the longer term, the market has actually risen by 13% in the last year. As for the next few years, earnings are expected to grow by 15% per annum. Market details ›